Dossier assessment
Cenobamate (epilepsy) - Benefit assessment according to §35a Social Code Book
Report documents
-
Extract of dossier assessment
Cenobamate (epilepsy) - Benefit assessment according to §35a Social Code Book
-
Dossier assessment
Cenobamate (epilepsy) - Benefit assessment according to §35a Social Code Book
Dossier assessment
Adjunctive treatment of focal-onset seizures with or without secondary generalization in adult patients with epilepsy who have not been adequately controlled despite a history of treatment with at least 2 anti-epileptic medicinal products
Added benefit not proven.
Additional information
Federal Joint Committee (G-BA)
19-11-2021 A G-BA decision was published.
Project details
- Project no.
- A21-78
- Commission
- Commission awarded on 31.05.2021 by the Federal Joint Committee (GBA).
- Report type
- Dossier assessment
- Status
- Commission completed
- Department/Division
- Drug Assessment
- Topic
- Head and nerves
- Note
-
After completion of the assessment by IQWiG the Federal Joint Committee (GBA) conducts a commenting procedure. This may provide supplementary information and as a result lead to a modified benefit assessment. Further information and the decision on the early benefit assessment can be found on the relevant page of the GBA website.